NCT01810367View on ClinicalTrials.gov

ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

ABX Combined With Cisplatin

DRUG

Gemcitabine Combined With Cisplatin

Trial Locations (1)

200032

Cancer hospital Fudan University, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT01810367 - ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC | Biotech Hunter | Biotech Hunter